Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Jul 20, 2022 7:12pm
81 Views
Post# 34838788

RE:RE:RE:POC

RE:RE:RE:POCRespectfully disagree.  It has to be both.  There were things THTX could've discussed publically to keep investors engaged and more fully aware of what all was happening without fabricating eroneous attempts at convincing people game changing discoveries were being made.  THTX has been a desert for most investors.  That needs to change.  Investors have left because they were left first.

That last press release was impressive though and gives me hope that they will be able to communicate meaningful details when they choose too.  Maybe they could drip seemingly non-meaningful details to us more frequently and at least keep investors engaged.

palinc2000 wrote:

Everyone is entitled to his opinion .My bigger point is that there has been a lot of rants here with a lot of blame agsinst management because people without scientific knowledge actually think that you are right about the likelyhood of success and cannot comprehend why mgmt is bot spreading the good news across the universe!!!
IF and when there are facts that support a probability of success you will hear about it on TV and read about it everywhere.
Of course everyone is free to believe that success is at hand but so far I have not seen anyone on this board doing any buying even though the best time to buy is NOW if of course you have faith in your opinion
Could management present a rosier picture of the company as a whole ? I think Scarlett had a post the other day with a list of items /facts which could be better disseminated .I do believe that the market cap of THTX is undervalued and should be at least double just based on its commercial activities but I think the market needs to see the pudding in the next 2 quarters

 

SPCEO1 wrote: Everyone will have their opinion on this but my read is we re already at a point where it is reasonably likely the key attributes for the success of TH-1902 are in place and th ekey causes of failure are absent. 
 

 

palinc2000 wrote: A Google search of POC will lead to many many definitions none of which to suggest that we are at that point ATM ....
What is worst than fuzzy math is fuzzy science data ...
When and if POC is attained we will know just by seeing the market reaction $$$
 “Proof of concept may be defined as the earliest point in the drug development process at which the weight of evidence suggests that it is "reasonably likely" that the key attributes for success are present and the key causes of failure are absent.” POC is a key translational pivot point ...

 




<< Previous
Bullboard Posts
Next >>